Stephen F. Mahoney, President and CEO at Viridian Therapeutics, Inc.\DE (VRDN), bought 42,800 shares at $23.33 ($999K) on 2024-09-27, disclosed to the SEC on 2024-09-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.33 | 21,400 | $499K | 50.0% |
| 2 | $23.33 | 21,400 | $499K | 50.0% |
| Total | $23.33 avg | 42,800 | $999K | 100% |